Researchers use skin-colonizing bacteria to create a topical cancer therapy in mice, News Center

In a study led by Stanford Medicine, researchers harnessed the skin’s immune response to bacteria to create an immunotherapy — delivered by swab — that treats aggressive tumors in mice.

Cationic Methacrylate Polymers as Topical Antimicrobial Agents against Staphylococcus aureus Nasal Colonization

News Bioengineering

Next Generation: Personalized Probiotic Skin Care

The human skin microbiome Nature Reviews Microbiology

Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications

Healthy gut bacteria can help fight cancer in other parts of the body - International Society of Microbiota

Developing a new class of engineered live bacterial therapeutics to treat human diseases

Akkermansia supplementation reduces ovarian cancer progression in mice - International Society of Microbiota

Engineered skin bacteria induce antitumor T cell responses against melanoma

Engineered E. coli for the in situ secretion of therapeutic nanobodies in the gut - International Society of Microbiota

Frontiers Secreted Toxins From Staphylococcus aureus Strains Isolated From Keratinocyte Skin Cancers Mediate Pro-tumorigenic Inflammatory Responses in the Skin

Next-Generation Hydrogels as Biomaterials for Biomedical Applications: Exploring the Role of Curcumin

Researchers use skin-colonizing bacteria to create a topical cancer therapy in mice

A Fascinating (and Unexpected) Discovery: A Potential Cancer Fighter in the Skin Microbiome